Quality metrics: FDA wants feedback on pared-down program
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)ComplianceNorth AmericaOTCPharmaceuticalsProduct LifecycleQuality Assurance and ControlRegulatory Intelligence/Policy